Seung-Hyo Lee

Seung-Hyo Lee

Auto-generated profile, based on publicly available information

Seung-Hyo Lee

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea; Department of Biomedical Science, College of Medicine, Korea University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2007 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
SLSeung-Hyo Lee
Seung-Hyo Lee
SGSangeeta Goswami
Sangeeta Goswami
AGAriel Grudo
Ariel Grudo
LSLi-Zhen Song
Li-Zhen Song
VBVenkata Bandi
Venkata Bandi
FKFarrah Kheradmand
Farrah Kheradmand

11 January 2019 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
IPInwon Park
Inwon Park
MKMingyo Kim
Mingyo Kim
KCKibaek Choe
Kibaek Choe
ESEunjoo Song
Eunjoo Song
HSHowon Seo
Howon Seo
PKPilhan Kim
Pilhan Kim
The lung is highly vulnerable during sepsis, yet its functional deterioration accompanied by disturbances in the pulmonary microcirculation is poorly understood. This study aimed to investigate how the pulmonary microcirculation is distorted in sepsis-induced acute lung injury (ALI) and reveal the underlying cellular pathophysiologic mechanism.Using a custom-made intravital lung microscopic imaging system in a murine model of sepsis-induced ALI, we achieved direct real-time visualisation of the pulmonary microcirculation and circulating cellsin vivo. We derived the functional capillary ratio (FCR) as a quantitative parameter for assessing the fraction of functional microvasculature in the pulmonary microcirculation and dead space.We identified that the FCR rapidly decreases in the early stage of sepsis-induced ALI. The intravital imaging revealed that this decrease resulted from the generation of dead space, which was induced by prolonged neutrophil entrapment within the capillaries. We further showed that the neutrophils had an extended sequestration time and an arrest-like dynamic behaviour, both of which triggered neutrophil aggregates inside the capillaries and arterioles. Finally, we found that Mac-1 (CD11b/CD18) was upregulated in the sequestered neutrophils and that a Mac-1 inhibitor restored the FCR and improved hypoxaemia.Using the intravital lung imaging system, we observed that Mac-1-upregulated neutrophil aggregates led to the generation of dead space in the pulmonary microcirculation that was recovered by a Mac-1 inhibitor in sepsis-induced ALI.

15 November 2002 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FKFarrah Kheradmand
Farrah Kheradmand
AKAttila Kiss
Attila Kiss
JXJie Xu
Jie Xu
SLSeung-Hyo Lee
Seung-Hyo Lee
PKPappachan E Kolattukudy
Pappachan E Kolattukudy
DCDavid B. Corry
David B. Corry
The respiratory allergens that induce experimental Th cell type 2-dependent allergic lung inflammation may be grouped into two functional classes. One class of allergens, in this study termed type I, requires priming with adjuvants remote from the lung to overcome airway tolerogenic mechanisms that ordinarily preclude allergic responses to inhaled Ags. In contrast, the other, or type II, allergen class requires neither remote priming nor additional adjuvants to overcome airway tolerance and elicit robust allergic lung disease. In this study, we show in an experimental model that diverse type II allergens share in common proteolytic activity that is both necessary and sufficient for overcoming airway tolerance and induction of pulmonary allergic disease. Inactivated protease and protease-free Ag fragments showed no allergenic potency, demonstrating that only active protease acting on endogenous substrates was essential. Furthermore, induction of airway tolerance could be aborted and allergic lung disease established by simply adding purified protease to a type I allergen. Thus, exogenous proteases are common to type II allergens and may be generally required to overcome the innate resistance of the airway to Th cell type 2 activation and allergic inflammation, raising concern for their potential contribution to diseases such as asthma.

1 January 2011 in Immunity
Verified
Journal Article
Closed access
RKRaghu P Kataru
Raghu P Kataru
HKHonsoul Kim
Honsoul Kim
CJCholsoon Jang
Cholsoon Jang
DCDong Kyu Choi
Dong Kyu Choi
BKBong Ihn Koh
Bong Ihn Koh
GKGou Young Koh
Gou Young Koh

1 April 2004 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DCDavid B. Corry
David B. Corry
AKAttila Kiss
Attila Kiss
LSLi-Zhen Song
Li-Zhen Song
LSLing Song
Ling Song
JXJie Xu
Jie Xu
FKFarrah Kheradmand
Farrah Kheradmand
The mechanisms that initiate allergic lung inflammation are relevant to expression of diseases such as asthma, but the factors underlying resolution of inflammation are equally important. Previously, we demonstrated the importance of matrix metalloproteinase 2 (MMP2) for airway egression of lung eosinophils, a critical anti‐inflammatory mechanism without which mice are rendered highly susceptible to lethal asphyxiation. Here we show that leukocyte MMP9 is the dominant airway MMP controlling inflammatory cell egression. The allergic lung phenotype of MMP9 −/− mice was similar to WT and was not altered by concomitant deletion of the MMP2 gene (double knockout; dko). However, inflammatory cells accumulated aberrantly in the lungs of allergen‐challenged MMP9 −/− and dko mice and fewer eosinophils and neutrophils were present in bronchoalveolar lavage. These aberrant cellular trafficking patterns were explained by disruption of transepithelial chemokine gradients, in MMP2 −/− mice affecting only eotaxin (CCL11), but in MMP9 −/− and dko mice involving eotaxin, MARC (CCL7), and TARC (CCL17). Thus, by establishing multiple transepithelial chemokine gradients, MMP9 is broadly implicated in the resolution of allergic inflammation, an essential protective mechanism that overlaps with a more limited role played by MMP2.

28 October 2009 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MSMing Shan
Ming Shan
HCHan-Fang Cheng
Han-Fang Cheng
LSLi-Zhen Song
Li-Zhen Song
LRLuz Roberts
Luz Roberts
LGLinda Green
Linda Green
FKFarrah Kheradmand
Farrah Kheradmand
Specialized immune cells in the lungs of patients with emphysema create an inflammatory environment that drives lung destruction in a characteristic autoimmune reaction.